Clinical Trial Detail

NCT ID NCT02672917
Title Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MabVax Therapeutics, Inc.
Indications

pancreatic ductal adenocarcinoma

Therapies

MVT-5873

Age Groups: adult senior

No variant requirements are available.